The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Penetral Roll-on
Capsaicin 0.025% · CAPSICUM OLEORESIN .25 mg/g · Gel · Topical · PureTek Corporation
NDC 59088-0329-07 · 85 g in 1 BOTTLE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for capsaicin (other) in the next 90 days
price up 12% YoY · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- M017
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Capsaicin 0.025% (Gel)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| PureTek Corporation | CAPSICUM OLEORESIN .25 mg/g | Jul 16, 2026 | Sep 3, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Penetral Roll-on — NDC 59088-0329-07," retrieved September 3, 2026, https://drugdashboards.com/drug/59088032907.
Free to cite with attribution — see how the data is put together.